Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiju Ji

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Nucleic Acids Research|August 9, 2003
Detection of methylation of human p16(Ink4a) gene 5'-CpG islands by electrochemical method coupled with linker-PCRPeng Hou, Meiju Ji, Cunwang Ge, et al.
Oncotargets and Therapy|November 11, 2020
Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid CancerXi Su, Jiaxin Liu, Haihong Zhang, et al.
Cell Death & Disease|August 4, 2021
Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotypeZhuanli Bai, Yiping Qu, Lin Shi, et al.
International Journal of Biological Macromolecules|July 20, 2023
Pin1 inhibitor API-1 sensitizes BRAF-mutant thyroid cancers to BRAF inhibitors by attenuating HER3-mediated feedback activation of MAPK/ERK and PI3K/AKT pathwaysHui Dang, Mengjun Sui, Qingyuan He, et al.
Clinical Biochemistry|May 3, 2003
A microarray to analyze methylation patterns of p16(Ink4a) gene 5'-CpG islandsPeng Hou, Meiju Ji, Zhengchun Liu, et al.
International Journal of Cancer|November 29, 2013
Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancersYiping Qu, Lei Shi, Dan Wang, et al.
Cancer|May 13, 2008
Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancerHaixia Guan, Meiju Ji, Peng Hou, et al.
BMC Cancer|October 9, 2013
Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathwayJiao Fu, Hongjun Lv, Haixia Guan, et al.
International Journal of Biological Sciences|February 7, 2020
NVP-BEZ235 inhibits thyroid cancer growth by p53- dependent/independent p21 upregulationBanjun Ruan, Wei Liu, Pu Chen, et al.
International Journal of Cancer|January 18, 2014
TERT promoter mutations predict worse survival in laryngeal cancer patientsYiping Qu, Siwen Dang, Kexia Wu, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Nucleic Acids Research|August 9, 2003
Detection of methylation of human p16(Ink4a) gene 5'-CpG islands by electrochemical method coupled with linker-PCRPeng Hou, Meiju Ji, Cunwang Ge, et al.
Oncotargets and Therapy|November 11, 2020
Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid CancerXi Su, Jiaxin Liu, Haihong Zhang, et al.
Cell Death & Disease|August 4, 2021
Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotypeZhuanli Bai, Yiping Qu, Lin Shi, et al.
International Journal of Biological Macromolecules|July 20, 2023
Pin1 inhibitor API-1 sensitizes BRAF-mutant thyroid cancers to BRAF inhibitors by attenuating HER3-mediated feedback activation of MAPK/ERK and PI3K/AKT pathwaysHui Dang, Mengjun Sui, Qingyuan He, et al.
Clinical Biochemistry|May 3, 2003
A microarray to analyze methylation patterns of p16(Ink4a) gene 5'-CpG islandsPeng Hou, Meiju Ji, Zhengchun Liu, et al.
International Journal of Cancer|November 29, 2013
Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancersYiping Qu, Lei Shi, Dan Wang, et al.
Cancer|May 13, 2008
Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancerHaixia Guan, Meiju Ji, Peng Hou, et al.
BMC Cancer|October 9, 2013
Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathwayJiao Fu, Hongjun Lv, Haixia Guan, et al.
International Journal of Biological Sciences|February 7, 2020
NVP-BEZ235 inhibits thyroid cancer growth by p53- dependent/independent p21 upregulationBanjun Ruan, Wei Liu, Pu Chen, et al.
International Journal of Cancer|January 18, 2014
TERT promoter mutations predict worse survival in laryngeal cancer patientsYiping Qu, Siwen Dang, Kexia Wu, et al.
Pageof 11